prednisolone has been researched along with Malignant Melanoma in 52 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pyrexia is the most common adverse event in patients with melanoma or other solid organ malignancies that are treated with the combination of dabrafenib and trametinib (combi-DT)." | 7.91 | Dynamics of neutrophil and C-reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib. ( Fujisawa, Y; Hiura, A; Kato, M; Maeda, T; Nagai, K; Oaku, S; Uehara, J; Yamashita, C; Yoshino, K, 2019) |
| "Pyrexia is the most common adverse event in patients with melanoma or other solid organ malignancies that are treated with the combination of dabrafenib and trametinib (combi-DT)." | 3.91 | Dynamics of neutrophil and C-reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib. ( Fujisawa, Y; Hiura, A; Kato, M; Maeda, T; Nagai, K; Oaku, S; Uehara, J; Yamashita, C; Yoshino, K, 2019) |
| " In contrast, betulinic acid, a novel chemotherapeutic compound, induced apoptosis and KILLER/DR5 mRNA in melanoma and glioblastoma cells through a p53-independent mechanism." | 3.71 | p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma. ( El-Deiry, WS; Meng, RD, 2001) |
| " However, the dosing and the duration of immunosuppressive therapy have not been systematically studied in the setting of treating ipilimumab-induced irAEs." | 2.52 | Ipilimumab-induced toxicities and the gastroenterologist. ( Bye, W; Cheng, R; Cooper, A; Kench, J; McNeil, C; Shackel, N; Watson, G, 2015) |
| "Hypophysitis is one of the more common adverse events, usually presenting with headache, pituitary enlargement and hypopituitarism, mostly ACTH deficiency, which is usually permanent." | 1.62 | Pituitary enlargement following ipilimumab without long term endocrine dysfunction. ( Brock, C; Dede, A; Larkin, J; Menon, A; Mitra, I; Morganstein, D; Nogueira, E, 2021) |
| " Although it is reported that myocarditis induced by the human anti-programmed death-1 inhibitor nivolumab therapy rarely occurred at > 2 months use in clinical trials, this case showed that even if at a late phase, long-term use of immune checkpoint inhibitors might to lead immune-related adverse events including myocarditis." | 1.48 | Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab. ( Akiyama, M; Fukaya, K; Haga, T; Hiraiwa, H; Ishii, H; Kano, N; Kohno, K; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Nakaguro, M; Okumura, T; Sawamura, A; Sugiura, Y; Watanabe, N; Yamaguchi, S; Yamashita, Y; Yokoi, T; Yokota, K, 2018) |
| "Subsequent imaging showed lymphadenopathy in the mediastinum and hilar regions that was confirmed to represent a sarcoid-like reaction at histologic examination." | 1.48 | Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma. ( Board, RE; Cheshire, SC; Dobson, MJ; Gudur, LD; Lewis, AR, 2018) |
| "Malignant melanoma has previously been reported with paraneoplastic syndromes including dermatomyositis." | 1.37 | Metastatic malignant melanoma and dermatomyositis: A paraneoplastic phenomenon. ( Tu, J; Von Nida, J, 2011) |
| "Clinically Wegener's granulomatosis can be divided into a limited and a generalized form." | 1.29 | Subretinal tumour in a patient with a limited form of Wegener's granulomatosis. ( Agostini, HT; Bräutigam, P; Löffler, KU, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (28.85) | 18.7374 |
| 1990's | 4 (7.69) | 18.2507 |
| 2000's | 3 (5.77) | 29.6817 |
| 2010's | 23 (44.23) | 24.3611 |
| 2020's | 7 (13.46) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuji, A | 1 |
| Hiramatsu, K | 1 |
| Namikawa, S | 1 |
| Yamamoto, A | 1 |
| Midori, Y | 1 |
| Murata, Y | 1 |
| Tanaka, T | 1 |
| Nosaka, T | 1 |
| Naito, T | 1 |
| Takahashi, K | 1 |
| Ofuji, K | 1 |
| Matsuda, H | 1 |
| Ohtani, M | 1 |
| Imamura, Y | 1 |
| Iino, S | 1 |
| Hasegawa, M | 1 |
| Nakamoto, Y | 1 |
| Tchernev, G | 1 |
| Oliveira, N | 1 |
| Kandathil, LJ | 1 |
| W Patterson, J | 1 |
| Lozev, I | 1 |
| Mozo Cuadrado, M | 1 |
| Tabuenca Del Barrio, L | 1 |
| Compains Silva, E | 1 |
| Ogawa-Momohara, M | 1 |
| Muro, Y | 1 |
| Goto, K | 1 |
| Obuse, C | 1 |
| Satoh, M | 1 |
| Kono, M | 1 |
| Akiyama, M | 2 |
| Asano, R | 1 |
| Kitazaki, Y | 1 |
| Ikawa, M | 1 |
| Kurebayasi, H | 1 |
| Koike, H | 1 |
| Hamano, T | 1 |
| Nogueira, E | 1 |
| Menon, A | 1 |
| Dede, A | 1 |
| Mitra, I | 1 |
| Brock, C | 1 |
| Larkin, J | 1 |
| Morganstein, D | 1 |
| Janssen, JBE | 1 |
| Leow, TYS | 1 |
| Herbschleb, KH | 1 |
| Gijtenbeek, JMM | 1 |
| Boers-Sonderen, MJ | 1 |
| Gerritsen, WR | 1 |
| Westdorp, H | 1 |
| Kiyohara, Y | 1 |
| Yoshikawa, S | 1 |
| Otsuka, M | 1 |
| Kondou, R | 1 |
| Iizuka, A | 1 |
| Nonomura, C | 1 |
| Ohshima, K | 1 |
| Urakami, K | 1 |
| Kusuhara, M | 1 |
| Nagashima, T | 1 |
| Sugino, T | 1 |
| Yamaguchi, K | 2 |
| Akiyama, Y | 1 |
| Tajmir-Riahi, A | 1 |
| Bergmann, T | 1 |
| Schmid, M | 1 |
| Agaimy, A | 1 |
| Schuler, G | 1 |
| Heinzerling, L | 1 |
| Denny, J | 1 |
| Chong, H | 1 |
| Akhras, V | 1 |
| Anastasopoulou, A | 1 |
| Papaxoinis, G | 1 |
| Diamantopoulos, P | 1 |
| Christofidou, E | 1 |
| Benopoulou, O | 1 |
| Stratigos, A | 1 |
| Gogas, H | 1 |
| Adler, NR | 1 |
| Murray, WK | 1 |
| Brady, B | 2 |
| McCormack, C | 1 |
| Pan, Y | 1 |
| Yamaguchi, S | 1 |
| Morimoto, R | 1 |
| Okumura, T | 1 |
| Yamashita, Y | 1 |
| Haga, T | 1 |
| Kuwayama, T | 1 |
| Yokoi, T | 1 |
| Hiraiwa, H | 1 |
| Kondo, T | 1 |
| Sugiura, Y | 1 |
| Watanabe, N | 1 |
| Kano, N | 1 |
| Kohno, K | 1 |
| Fukaya, K | 1 |
| Sawamura, A | 1 |
| Yokota, K | 1 |
| Ishii, H | 1 |
| Nakaguro, M | 1 |
| Murohara, T | 1 |
| Cheshire, SC | 1 |
| Board, RE | 1 |
| Lewis, AR | 1 |
| Gudur, LD | 1 |
| Dobson, MJ | 1 |
| Nobashi, T | 1 |
| Mittra, E | 1 |
| Rischin, A | 1 |
| McLean, C | 1 |
| Ostor, AJK | 1 |
| Sızmaz, S | 1 |
| Görkemli, N | 1 |
| Esen, E | 1 |
| Demircan, N | 1 |
| Maeda, T | 1 |
| Yoshino, K | 2 |
| Yamashita, C | 1 |
| Nagai, K | 1 |
| Oaku, S | 1 |
| Kato, M | 1 |
| Hiura, A | 1 |
| Uehara, J | 1 |
| Fujisawa, Y | 1 |
| Feist, J | 1 |
| Murray, A | 1 |
| Skapenko, A | 1 |
| Schulze-Koops, H | 1 |
| De Sousa, SM | 1 |
| Long, GV | 1 |
| Tonks, KT | 1 |
| Cheng, R | 1 |
| Cooper, A | 1 |
| Kench, J | 1 |
| Watson, G | 1 |
| Bye, W | 1 |
| McNeil, C | 1 |
| Shackel, N | 1 |
| Miserocchi, E | 1 |
| Cimminiello, C | 1 |
| Mazzola, M | 1 |
| Russo, V | 1 |
| Modorati, GM | 1 |
| Woods, JA | 1 |
| Ferguson, JS | 1 |
| Kalra, S | 1 |
| Degabriele, A | 1 |
| Gardner, J | 1 |
| Logan, P | 1 |
| Ferguson, J | 1 |
| Kanameishi, S | 1 |
| Otsuka, A | 1 |
| Nonomura, Y | 1 |
| Fujisawa, A | 1 |
| Endo, Y | 1 |
| Kabashima, K | 1 |
| Chu, CH | 1 |
| Cheng, YP | 1 |
| Kao, HL | 1 |
| Liang, CW | 1 |
| Chan, JY | 1 |
| Yu, Y | 1 |
| Tsuboi, S | 1 |
| Imafuku, K | 1 |
| Ohara, K | 1 |
| Tanaka, A | 1 |
| Ikinaga, K | 1 |
| Kiyohara, E | 1 |
| Tanemura, A | 1 |
| Wataya-Kaneda, M | 1 |
| Fujimura, R | 1 |
| Mizui, M | 1 |
| Isaka, Y | 1 |
| Katayama, I | 1 |
| Herz, S | 1 |
| Höfer, T | 1 |
| Papapanagiotou, M | 1 |
| Leyh, JC | 1 |
| Meyenburg, S | 1 |
| Schadendorf, D | 1 |
| Ugurel, S | 1 |
| Roesch, A | 1 |
| Livingstone, E | 1 |
| Schilling, B | 1 |
| Franklin, C | 1 |
| Filippi, M | 1 |
| Catanzaro, V | 1 |
| Patrucco, D | 1 |
| Botta, M | 1 |
| Tei, L | 1 |
| Terreno, E | 1 |
| Tu, J | 1 |
| Von Nida, J | 1 |
| KAUFMAN, HE | 1 |
| Narita, Y | 1 |
| Kimura, M | 1 |
| Nishihira, T | 1 |
| Kasai, M | 1 |
| Sato, H | 1 |
| Bast, RC | 1 |
| Reinherz, EL | 1 |
| Maver, C | 1 |
| Lavin, P | 1 |
| Schlossman, SF | 1 |
| Bhakoo, HS | 1 |
| Paolini, NS | 1 |
| Milholland, RJ | 1 |
| Lopez, RE | 1 |
| Rosen, F | 1 |
| Selby, PJ | 1 |
| Millar, JL | 1 |
| Phelps, TA | 1 |
| Gordon, MY | 1 |
| Wilkinson, R | 1 |
| McElwain, TJ | 1 |
| Remulla, JF | 1 |
| Pineda, R | 1 |
| Gaudio, AR | 1 |
| Milam, AH | 1 |
| Norman, RA | 1 |
| Liberman, RB | 1 |
| Przyjemski, C | 1 |
| Girshovich, L | 1 |
| Agostini, HT | 1 |
| Bräutigam, P | 1 |
| Löffler, KU | 1 |
| Meng, RD | 1 |
| El-Deiry, WS | 1 |
| Kennedy, RD | 1 |
| McAleer, JJ | 1 |
| Bobrova, VN | 1 |
| Gavrilenko, IS | 1 |
| Ivanov, II | 1 |
| Shestakov, AD | 1 |
| Trapeznikov, NN | 1 |
| Kupin, VI | 1 |
| Radzikhovskaia, RM | 1 |
| Kadagidze, ZG | 1 |
| Yap, EY | 1 |
| Robertson, DM | 1 |
| Buettner, H | 1 |
| Birkeland, SA | 1 |
| Kemp, E | 1 |
| Davies, EW | 1 |
| Sanders, MD | 1 |
| Harry, J | 1 |
| Evans, DB | 1 |
| Calne, RY | 1 |
| Kretschmer, H | 2 |
| Grässer, A | 1 |
| Ludewig, R | 1 |
| Hambsch, K | 1 |
| Wohlrab, W | 1 |
| Peker, J | 1 |
| Grigor'ian, VL | 1 |
| Ryan, SJ | 1 |
| Frank, RN | 1 |
| Green, WR | 1 |
6 reviews available for prednisolone and Malignant Melanoma
| Article | Year |
|---|---|
[A case of post-surgical inflammatory neuropathy with lower-extremity weakness after surgery for anorectal malignant melanoma that showed the effectiveness of immunotherapy].
Topics: Administration, Oral; Anus Neoplasms; Humans; Inflammation; Male; Melanoma; Middle Aged; Peripheral | 2020 |
Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the Literature.
Topics: Aged; Antibodies, Monoclonal, Humanized; Fatal Outcome; Guillain-Barre Syndrome; Humans; Immune Chec | 2021 |
Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.
Topics: Antineoplastic Agents, Immunological; Eosinophilia; Humans; Immunoglobulin E; Lymph Nodes; Male; Mel | 2018 |
Ipilimumab-induced toxicities and the gastroenterologist.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury | 2015 |
THE UVEA.
Topics: Anatomy; Arthritis; Autoantibodies; Betamethasone; Dexamethasone; Dihydroxyphenylalanine; Epidemiolo | 1964 |
[Chemotherapy for brain metastases].
Topics: Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasm | 2005 |
1 trial available for prednisolone and Malignant Melanoma
| Article | Year |
|---|---|
A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
Topics: Adolescent; Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Lymphoid; | 1977 |
45 other studies available for prednisolone and Malignant Melanoma
| Article | Year |
|---|---|
A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma.
Topics: Aged; Antineoplastic Agents, Immunological; Enteritis; Eosinophilia; Female; Gastritis; Humans; Immu | 2022 |
Mucocutaneous Melanoma - A Diagnostic and Therapeutic Problem.
Topics: Aged; Humans; Melanoma; Mouth Neoplasms; Mycophenolic Acid; Prednisolone; Salicylic Acid; Skin Neopl | 2022 |
Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma.
Topics: Aged; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; Epiretinal Membrane; F | 2021 |
Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Autoantibodies; Autoantigens; Facial Neoplasms | 2020 |
Pituitary enlargement following ipilimumab without long term endocrine dysfunction.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Female; Glucocorticoids; Humans | 2021 |
Melanoma patient response to nivolumab treatment for metastatic lung lesions: Multi-OMICS analysis in Project HOPE.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasm | 2017 |
Life-threatening Autoimmune Cardiomyopathy Reproducibly Induced in a Patient by Checkpoint Inhibitor Therapy.
Topics: Aged; Antibodies, Monoclonal; Arm; CTLA-4 Antigen; Fatal Outcome; Heart Arrest; Humans; Immunotherap | 2018 |
Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; C | 2018 |
Sweet syndrome associated with ipilimumab in a patient with metastatic melanoma.
Topics: Aged; Antineoplastic Agents, Immunological; Betamethasone; Glucocorticoids; Humans; Ipilimumab; Male | 2018 |
Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab.
Topics: Antineoplastic Agents, Immunological; B7-H1 Antigen; Glucocorticoids; Humans; Immunoglobulins, Intra | 2018 |
Pembrolizumab-induced Sarcoid-like Reactions during Treatment of Metastatic Melanoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Biopsy; Female; Glucocortic | 2018 |
PD-1 Blockade-induced Inflammatory Arthritis.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Arthritis; Fluorodeox | 2018 |
Immune checkpoint inhibitor-induced lymphocytic fasciitis.
Topics: Antineoplastic Agents, Immunological; Biopsy; Fasciitis; Forearm; Humans; Immunosuppressive Agents; | 2018 |
A Rare Cause of Uveitis: Vemurafenib
Topics: Administration, Oral; Adult; Anterior Chamber; Anti-Inflammatory Agents; Antineoplastic Agents; Fema | 2018 |
Dynamics of neutrophil and C-reactive protein reflect the clinical course of pyrexia during combination therapy with dabrafenib and trametinib.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; C-Rea | 2019 |
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Immunological; Etoricoxib; Glucocort | 2019 |
Ipilimumab-induced hypophysitis: early Australian experience.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Australia; Disease Progression; Glucocorticoids; Huma | 2014 |
New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; CTLA-4 Antigen; Female; Glucocorticoids; Humans | 2015 |
The phototoxicity of vemurafenib: An investigation of clinical monochromator phototesting and in vitro phototoxicity testing.
Topics: Cell Line; Chlorpromazine; Chromatography, High Pressure Liquid; Dermatitis, Phototoxic; Dexamethaso | 2015 |
Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; B-Lymphocytes; Female; Humans; Immunoglobulins, | 2016 |
Lymphedema-associated neutrophilic dermatosis: Two cases of localized Sweet syndrome on the lymphedematous lower limbs.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Biopsy; C-Reactive Protein; Cephalosporins; Femal | 2016 |
Two cases of successful treatment for severe skin rash induced by vemurafenib following nivolumab therapy without cessation of vemurafenib.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Exanthema; Female; Glucocorticoids; Hum | 2017 |
Critical renal adverse event induced by nivolumab therapy in a stage IV melanoma patient.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Antineoplastic Agents; beta 2-Microglobulin; Biopsy | 2017 |
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; CTLA-4 Antigen; Graft Reject | 2016 |
First in vivo MRI study on theranostic dendrimersomes.
Topics: Animals; Cell Line, Tumor; Contrast Media; Dendrimers; Female; Glucocorticoids; Heterocyclic Compoun | 2017 |
Metastatic malignant melanoma and dermatomyositis: A paraneoplastic phenomenon.
Topics: Adult; Alendronate; Antibodies, Antinuclear; Calcium; Dermatologic Agents; Dermatomyositis; Drug The | 2011 |
Differentiative and proliferative effects of (But)2cAMP, n-butyric acid and prednisolone on the malignant melanoma cell line (TM-1) in vitro and in vivo.
Topics: Animals; Bucladesine; Butyrates; Cell Differentiation; Cell Division; Cell Line; Melanoma; Mice; Neo | 1980 |
Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes.
Topics: Adult; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; B-Lymphocytes; Cyclophosphamide; | 1983 |
Glucocorticoid receptors and the effect of glucocorticoids on the growth of B16 melanoma.
Topics: Animals; Dexamethasone; Female; Hydrocortisone; Lung Neoplasms; Male; Melanoma; Mice; Neoplasm Trans | 1981 |
The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systems.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Interactions; Drug Therapy, Combination; Humans; | 1981 |
Cutaneous melanoma-associated retinopathy with retinal periphlebitis.
Topics: Electroretinography; Fluorescein Angiography; Fundus Oculi; Humans; Male; Melanoma; Middle Aged; Nig | 1995 |
Diffuse histiocytic lymphoma treated with chemotherapy and radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 1996 |
Subretinal tumour in a patient with a limited form of Wegener's granulomatosis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic A | 1995 |
p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma.
Topics: Antibiotics, Antineoplastic; Apoptosis; Betulinic Acid; Colonic Neoplasms; Dactinomycin; Dexamethaso | 2001 |
Radiation recall dermatitis in a patient treated with dacarbazine.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Glucocorticoids | 2001 |
[Radiotherapeutic effect of naphthidon-3H in combined action on Harding-Passey melanoma].
Topics: Animals; Antineoplastic Agents; Autoradiography; Cyclophosphamide; Drug Therapy, Combination; Histoc | 1975 |
[Evaluation of the immunological reactivity of melanoma patients using the rosette formation test].
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immune Adherence Reaction; Immunosuppre | 1975 |
Scleritis as an initial manifestation of choroidal malignant melanoma.
Topics: Adult; Choroid Neoplasms; Eye Enucleation; Female; Humans; Male; Melanoma; Middle Aged; Prednisolone | 1992 |
Malignant tumours following immunosuppression in renal transplantation.
Topics: Adenocarcinoma; Adult; Azathioprine; Brain Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinom | 1973 |
Annular serous detachment of the choroid.
Topics: Adult; Choroid; Diagnosis, Differential; Edema; Electrooculography; Eye Diseases; Female; Fluorescei | 1973 |
Renal transplantation in patients with carcinoma.
Topics: Adult; Angiography; Azathioprine; Cadaver; Female; Graft Rejection; Hematuria; Humans; Immunosuppres | 1974 |
[Serological studies using clostridial spores for tumor diagnosis. I. Transplantable tumors in rats and hamsters].
Topics: Animals; Antibodies, Bacterial; Antibody Formation; Clostridium; Cricetinae; Cyclophosphamide; Male; | 1973 |
[Therapeutic studies of Clostridium butyricum spores, cyclophosphamide and prednisolone in amelanotic melanoma in Syrian gold hamsters].
Topics: Animals; Antibodies, Bacterial; Clostridium; Cricetinae; Cyclophosphamide; Drug Evaluation, Preclini | 1973 |
[The effects of corticosteroids and roentgen irradiation on the growth of transplantable Harding-Passey melanoma].
Topics: Animals; Hydrocortisone; Male; Melanoma; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Pr | 1969 |
Bilateral inflammatory pseudotumors of the ciliary body.
Topics: Administration, Topical; Anti-Inflammatory Agents; Atropine; Biopsy; Ciliary Body; Diagnosis, Differ | 1971 |